Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
Top Cited Papers
- 1 August 2000
- Vol. 56 (2) , 255-260
- https://doi.org/10.1016/s0090-4295(00)00637-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIALJournal of Urology, 1999
- THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGENJournal of Urology, 1998
- Comparison of Percent Free Prostate Specific Antigen and Prostate Specific Antigen Density as Methods to Enhance Prostate Specific Antigen Specificity in Early Prostate Cancer Detection in Men With Normal Rectal Examination and Prostate Specific Antigen Between 4.1 and 10 ng./ml.Journal of Urology, 1997
- The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General PopulationJournal of Urology, 1997
- Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate CancerJournal of Urology, 1996
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- The TNM classification of prostate cancerThe Prostate, 1992
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990